Monday, June 17, 2013

Health News: [diabetes ]: Lilly Diabetes, Kris Freeman Kick off Summer with 9th Annual Diabetes Summer Camp Tour

Yahoo! Health   |  My alerts   |   Edit Alert
Monday, Jun 17, 2013 08:11 AM EDT
 
   Health News : diabetes - News from Yahoo !
 
Lilly Diabetes, Kris Freeman Kick...
Mon, 17 Jun, 2013 05:00 AM PDT
INDIANAPOLIS, June 17, 2013 /PRNewswire/ -- News Highlights #T1DiabetesChamp Kris Freeman @TeamFreeB...
Continue reading
MannKind Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 2 Diabetes
Mon, 17 Jun, 2013 05:00 AM PDT
MannKind Corporation today announced that all follow-up visits have been completed for the patients enrolled in Study 175, a Phase 3 clinical study of AFREZZA® inhalation powder, an investigational, ultra rapid-acting mealtime insulin therapy, administered using MannKind's next-generation inhaler.
Continue reading
Biodel Announces Data Presentations at American Diabetes Association Annual Meeting
Mon, 17 Jun, 2013 03:00 AM PDT
- Selected by ADA for late breaking presentation of Biodel's proprietary ultra-rapid-acting analog formulations
Continue reading
 
   Health News : diabetes - Top images.
 
 
   Health News : diabetes - News from other sources.
 
Transition, Lilly amend agreement to address future development of TT-401
Mon, 17 Jun, 2013 04:33 AM PDT
Transition Therapeutics Inc. announced that Eli Lilly and Company has exercised its option to assume all development and commercialization rights to type 2 diabetes drug candidate TT-401.
Continue reading
Youngsters' day of activities for diabetes
Mon, 17 Jun, 2013 04:33 AM PDT
Youngsters learned about diabetes during a day of dressing up and activities tied in with an awareness week.
Continue reading
Boost for diabetes patients at Dorchester hospital
Mon, 17 Jun, 2013 04:29 AM PDT
MEDICS have said thank you for donations which enabled them to buy new equipment for treating diabetes.
Continue reading
Stem cell breakthrough can lead to one diabetes jab a year
Mon, 17 Jun, 2013 04:09 AM PDT
Not a member? FORGOT PASSWORD? Enter your registered email below and we will send your password to this address. Not a member?
Continue reading
Novo Drops as New Lilly Drug Threatens Victoza: Copenhagen Mover
Mon, 17 Jun, 2013 03:35 AM PDT
Novo Nordisk A/S (NOVOB) fell the most among benchmark stocks in Copenhagen trading after Bank of America Merrill Lynch said the diabetes drug company's Victoza medicine faces "a real threat" from an Eli Lilly & Co. (LLY) product.
Continue reading
Worried about type 2 diabetes? Walk after every meal
Mon, 17 Jun, 2013 03:28 AM PDT
A new study shows the benefits of walking for 15 minutes after every meal.
Continue reading
Transition Therapeutics Announces Exercise of TT-401 Rights by Lilly
Mon, 17 Jun, 2013 03:23 AM PDT
TORONTO, June 17, 2013 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced that Eli Lilly and Company ("Lilly") has exercised its option to assume all development and commercialization rights to type 2 diabetes drug candidate...
Continue reading
You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.

No comments:

Post a Comment